NCT01608152Active, not recruiting
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
Using Game Mechanics to Improve Outcomes Among Stem Cell Transplant Survivors
Source: ClinicalTrials.gov · Last updated 15 Jul 2026
Brief summary (registry, in English)
This trial collects feedback from patients to develop a video game in improving the outcomes in stem cell transplant survivors. A video game may help to improve health behaviors for leukemia or lymphoma patients after stem cell transplant.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 144 (actual)
- First submitted
- 25 May 2012
- Start date
- 20 Feb 2013
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- M.D. Anderson Cancer Center
- Diseases
- Childhood cancers
- NCT number
- NCT01608152
What you commit to
- Study type: Observational
- Participants enrolled: 144
- From 20 Feb 2013 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- They have an intellectual deficiency that would prevent the potential participant from understanding information delivered on the computer platform or as defined by the DSM-V Diagnostic and Statistical Manual of Mental Disorders that would prevent them from understanding information delivered on the computer platform.
Other
- Phase I
- The target population will be excluded if:
- They do not speak English
- They have vision problems
- They have cognitive problems
- They have psychological difficulties
- Phase II
- The target population will be excluded if:
- They do not speak English
- They have vision problems that would preclude them from viewing a computer screen.
Who the study is looking for
- Phase I
- The target population for this study will consist of:
- Individuals ages 15-29
- Able to read and speak English
- Diagnosis of leukemia or lymphoma
- First time allogeneic SCT recipient
- Phase II
- The target population for this study will consist of:
- Individuals ages 18-39 (in phase I, we recruited only individuals age 15-29. For phase II, we will recruit young adults, and will expand the eligible age range up to 39 years. This expansion in age eligibility to 39 years is consistent with the National Cancer Institute definition of adolescents and young adults with cancer, and is consistent with the age range of patients seen at MD Anderson in the Adolescent and Young Adult Center.
- Able to read and speak English
- Diagnosis of leukemia or lymphoma (including Myelodysplastic Syndrome - MDS) or lymphoma
- HSCT recipient
Age in the registry: 15 years to 39 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| M D Anderson Cancer Center Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.